FR2866566A1 - Utilisation d'un inhibiteur de la secretion d'il-5,il-6 et/ou il-10 pour le traitement de la rosacee - Google Patents

Utilisation d'un inhibiteur de la secretion d'il-5,il-6 et/ou il-10 pour le traitement de la rosacee

Info

Publication number
FR2866566A1
FR2866566A1 FR0401718A FR0401718A FR2866566A1 FR 2866566 A1 FR2866566 A1 FR 2866566A1 FR 0401718 A FR0401718 A FR 0401718A FR 0401718 A FR0401718 A FR 0401718A FR 2866566 A1 FR2866566 A1 FR 2866566A1
Authority
FR
France
Prior art keywords
compounds
interleukin
metronidazole
pharmaceutical compositions
prepare pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
FR0401718A
Other languages
English (en)
Inventor
Fabrizio Folfi
Irina Safonova
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Research and Development SNC
Original Assignee
Galderma Research and Development SNC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Research and Development SNC filed Critical Galderma Research and Development SNC
Priority to FR0401718A priority Critical patent/FR2866566A1/fr
Priority to CA002553189A priority patent/CA2553189A1/fr
Priority to PCT/FR2005/000368 priority patent/WO2005079786A1/fr
Priority to US10/589,967 priority patent/US20070189985A1/en
Priority to EP05729331A priority patent/EP1722774A1/fr
Publication of FR2866566A1 publication Critical patent/FR2866566A1/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention se rapporte à l'utilisation d'un composé, modifiant, et de façon avantageuse inhibant, la sécrétion d'au moins une interleukine choisie dans le groupe comprenant l'IL-5, l'IL-6 et l'IL-10, pour la préparation d'une composition pharmaceutique destinée au traitement de la rosacée.
FR0401718A 2004-02-20 2004-02-20 Utilisation d'un inhibiteur de la secretion d'il-5,il-6 et/ou il-10 pour le traitement de la rosacee Pending FR2866566A1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR0401718A FR2866566A1 (fr) 2004-02-20 2004-02-20 Utilisation d'un inhibiteur de la secretion d'il-5,il-6 et/ou il-10 pour le traitement de la rosacee
CA002553189A CA2553189A1 (fr) 2004-02-20 2005-02-17 Utilisation d'un compose modifiant la secretion de l'interleukine 5, de l'interleukine 6 et/ou de l'interleukine 10 pour la preparation d'une composition pharmaceutique destinee atraiter la rosacee
PCT/FR2005/000368 WO2005079786A1 (fr) 2004-02-20 2005-02-17 Utilisation d’un compose modifiant la secretion de l’interleukine 5, de l’interleukine 6 et/ou de l’interleukine 10 pour la preparation d’une composition pharmaceutique destinee a traiter la rosacee
US10/589,967 US20070189985A1 (en) 2004-02-20 2005-02-17 Use of a compound modifying an interleukin 5, interleukin 6 and/or interleukin 10 secretion for preparing a pharmaceutical composition for rosacea treatment
EP05729331A EP1722774A1 (fr) 2004-02-20 2005-02-17 Utilisation d'un compose modifiant la secretion de l'interleukine 5, de l'interleukine 6 et/ou de l'interleukine 10 pour la preparation d'une composition pharmaceutique destinee a traiter la rosacee

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0401718A FR2866566A1 (fr) 2004-02-20 2004-02-20 Utilisation d'un inhibiteur de la secretion d'il-5,il-6 et/ou il-10 pour le traitement de la rosacee

Publications (1)

Publication Number Publication Date
FR2866566A1 true FR2866566A1 (fr) 2005-08-26

Family

ID=34833943

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0401718A Pending FR2866566A1 (fr) 2004-02-20 2004-02-20 Utilisation d'un inhibiteur de la secretion d'il-5,il-6 et/ou il-10 pour le traitement de la rosacee

Country Status (5)

Country Link
US (1) US20070189985A1 (fr)
EP (1) EP1722774A1 (fr)
CA (1) CA2553189A1 (fr)
FR (1) FR2866566A1 (fr)
WO (1) WO2005079786A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2723892A2 (fr) * 2011-06-27 2014-04-30 Galderma Research & Development Nouveaux marqueurs de différenciationth7 pour la rosacée et utilisations de ces derniers

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2728165A1 (fr) * 1994-12-19 1996-06-21 Oreal Utilisation d'un antagoniste de substance p pour le traitement des rougeurs cutanees d'origine neurogene
WO2001035965A1 (fr) * 1999-11-18 2001-05-25 Bolla John D Traitement de l'acne rosacee
US7074832B2 (en) * 2001-09-24 2006-07-11 Bradley Pharmaceuticals, Inc. Compositions containing antimicrobials and urea for the treatment of dermatological disorders and methods for their use
US6881726B2 (en) * 2001-12-24 2005-04-19 Dow Pharmaceutical Sciences Aqueous compositions containing metronidazole
JP2006516957A (ja) * 2002-11-15 2006-07-13 セントカー・インコーポレーテツド Ｉｌ−６アンタゴニストの抗血管形成用途

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
No Search *

Also Published As

Publication number Publication date
US20070189985A1 (en) 2007-08-16
WO2005079786A1 (fr) 2005-09-01
CA2553189A1 (fr) 2005-09-01
EP1722774A1 (fr) 2006-11-22

Similar Documents

Publication Publication Date Title
MX2020008271A (es) Inhibidor de fap.
EA201170521A1 (ru) Новые соединения
EA200970542A1 (ru) ИНГИБИТОРЫ ДЕЙСТВИЯ Akt
MX358617B (es) Formulaciones de inhibidores de dpp iv.
GEP20125511B (en) Mapk/erk kinase inhibitors
MX2009011210A (es) Inhibidores de mcl1 de indol 7-no sustituido.
MX2009011211A (es) Indoles sustituidos en la posicion 7 inhibidores de mci-1.
EA200870292A1 (ru) Соединения на основе имидазола, композиции, содержащие их, и способы их применения
MX2009010207A (es) Peptidos de hidrazido como inhibidores de proteasa ns3 de virus de hepatitis c.
EA201270184A1 (ru) Лечение расстройств печени ингибиторами pi3k
TR201818983T4 (tr) İnflamatuvar Cilt Bozukluklarının Tedavisine Yönelik Olarak Sübstitüe Edilmiş Tetrasiklin Bileşikleri
EA200602241A1 (ru) Замещённые индазолы, композиции, содержащие указанные индазолы, способ их получения и применение
MX2009012000A (es) Derivados de pirazol heteroarilo sustituidos utiles para el tratamiento de trastornos hiperproliferativos y enfermedades asociadas a la angiogenesis.
WO2006135627A3 (fr) Inhibiteurs de l'activite akt
WO2008002570A3 (fr) Inhibiteurs de la protéine humaine tyrosine phosphatase et leurs procédés d'utilisation
WO2008002569A3 (fr) Inhibiteurs de la protéine humaine tyrosine phosphatase et leurs procédés d'utilisation
WO2009114725A3 (fr) Mobilisation de cellules souches hématopoïétiques
EA201170160A1 (ru) Новые ингибиторы пролиферации и активации переносчика сигнала и активатора транскрипции (stats)
EA200900091A1 (ru) Новые показания к применению прямых ингибиторов тромбина в лечении сердечно-сосудистых заболеваний
MX2009009153A (es) Pirano-pirazol-aminas.
NO20075764L (no) Kombinert anvendelse av prostaglandinforbindelse og protonpumpeinhibitor til behandling av forstyrrelser i mage- og tarmkanalen
WO2011116026A3 (fr) Inhibiteurs des interactions de liaison de sous unité alpha d'intégrine ƒà-de protéine g
MY152685A (en) Imidazopyridazines as par1 inhibitors, production thereof, and use thereof as medicaments
FR2866566A1 (fr) Utilisation d'un inhibiteur de la secretion d'il-5,il-6 et/ou il-10 pour le traitement de la rosacee
AU2018258588A8 (en) Inhibitors of TRIM33 and methods of use